【レポートの概要(一部)】
1. Report Overview
1.1 How This Report Delivers Information
1.2 Main Questions This Report Answers
1.3 Who is This Report For?
1.4 Methods of Research and Analysis
1.5 Frequently Asked Questions (FAQs)
1.6 Some Related Reports
1.7 About Visiongain
2. An Introduction to In Vitro Diagnostics
2.1 The In Vitro Diagnostics Market
2.1.1 The In Vitro Diagnostics Market in 2017
2.2 What are In Vitro Diagnostic (IVD) Tests?
2.3 Classifying In Vitro Diagnostics
2.3.1 The US Classification
2.3.2 The EC (European Commission) Classification
2.3.3 Regulatory Issues in the IVD Market
2.3.3.1 Regulation of IVD Tests
2.3.3.2 Lack of Clarity Can be Costly
2.4 Types of IVD Test
2.4.1 Point of Care Diagnostics
2.4.2 Clinical Chemistry
2.4.3 Microbiology
2.4.3.1 Regulatory Differences with IVD Microbiology Tests
2.4.4 Haematology
2.4.5 Immunochemistry
2.4.6 Genetic Testing
2.5 The IVD Market: Overall Revenue Forecast to 2027
2.5.1 Market Drivers, 2016-2027
2.5.2 Market Restraints, 2016-2027
2.5.3 Future of the IVD Industry
2.6 Company Comparison
2.6.1 Fragmented Market
2.6.2 IVD Market: Leading Manufacturers in 2016
3. The Leading US In Vitro Diagnostic Companies, 2016-2027
3.1 Danaher
3.1.1 Sales and Recent Performance Analysis
3.1.2 Life Sciences and Diagnostics
3.1.3 Key Products
3.1.4 Danaher Manufacturing Capabilities
3.1.5 Danaher IVD Segment: Strengths and Challenges
3.1.6 Danaher’s Life Sciences and Diagnostics Revenues
3.1.6.1 IVD Revenue Forecast, 2016-2027
3.1.7 Recent Mergers and Acquisition (M&A) Activity
3.2 Abbott Laboratories
3.2.1 Sales and Recent Performance Analysis
3.2.2 Abbott: Diagnostics Segment
3.2.2.1 In Vitro Diagnostics Products
3.2.3 Abbott IVD Segment: Strengths and Challenges
3.2.4 Abbott Diagnostics Historical Revenues, 2013-2015
3.2.5 IVD Revenue Forecast, 2016-2027
3.2.6 Recent M&A Activity and Strategic Collaborations
3.2.6.1 Collaboration with GSK
3.2.6.2 Collaboration with Merck
3.2.6.3 Acquisition of STARLIMS Technologies
3.2.6.4 Acquisition of Ibis Biosciences, Inc.
3.2.7 Plans to Separate into Two Publicly Traded Companies
3.3 Johnson & Johnson (J&J)
3.4 Bio-Rad
3.4.1 Sales and Recent Performance Analysis
3.4.2 Clinical Diagnostics
3.4.2.1 In Vitro Diagnostics
3.4.3 IVD Revenue 2015
3.4.4 IVD Revenue Forecast, 2017-2026
3.4.5 Recent M&A Activity and Strategic Collaborations
3.4.6 Potential Bio-Rad Labs Takeover Seen in Near-Term
3.5 Becton Dickinson
3.5.1 Global Presence
3.5.2 Distribution
3.5.3 R&D
3.5.4 Sales and Recent Performance Analysis
3.5.4.1 Historical Sales Performance Analysis
3.5.5 BD Diagnostics Revenue
3.5.6 IVD Revenue Forecast, 2017-2027
3.5.7 Recent M&A Activity and Strategic Collaborations
3.6 Thermo Fisher Scientific
3.6.1 Historical Sales and Recent Performance Analysis
3.6.2 Clinical Diagnostics
3.6.3 Key Products
3.6.4 Thermo Fisher’s Manufacturing Capabilities
3.6.5 Thermo Fisher’s Diagnostics Revenues
3.6.6 IVD Revenue Forecast 2016-2027
3.6.7 Recent Mergers and Acquisition Activity
3.6.7.1 Acquisition of Dionex and Phadia
4. The Leading European In Vitro Diagnostic Companies, 2016-2027
4.1 Roche
4.1.1 Global Presence
4.1.2 Sales and Recent Performance Analysis
4.1.3 Roche Diagnostics
4.1.4 R&D Capabilities
4.1.5 Growing Portfolio of Diagnostic Products
4.1.5.1 Exploring Strategies in the Neurological Sector
4.1.6 IVD Revenue Forecast 2016-2027
4.1.7 Recent M&A Activity and Strategic Collaborations
4.1.7.1 Roche Offers to Acquire Illumina to Strengthen its Leading Position in Diagnostics
4.2 Siemens
4.2.1 Sales and Recent Performance, 2015
4.2.2 Siemens Healthcare
4.2.2.1 Siemens Diagnostics
4.2.2.2 Outperforming the Market
4.2.2.3 In Vitro Diagnostics
4.2.3 IVD Revenue Forecast 2016-2027
4.2.4 Recent M&A Activity and Strategic Collaborations
4.2.4.1 Partnership with ViiV Healthcare
4.2.4.2 Partnership with Tocagen
4.3 bioMérieux
4.3.1 Sales and Recent Performance, 2015
4.3.2 IVD Revenue Forecast 2016-2027
4.3.3 Recent M&A Activity and Strategic Collaborations
4.3.3.1 Partnership with GSK
4.3.3.2 Partnership with Ipsen
4.3.3.3 Partnership with Institute Merieux and Institute Pasteur
4.3.3.4 Collaboration with Hospices Civils de Lyon
4.3.3.5 Acquisition of ARGENE
4.3.3.6 Equity Interest in Knome
5. The Leading Japanese In Vitro Diagnostic Companies, 2016-2027
5.1 Sysmex
5.1.1 Global Presence and Distribution
5.1.2 Sales and Recent Performance Analysis
5.1.3 Sysmex Diagnostics
5.1.4 IVD Revenue Forecast 2016-2027
5.1.5 Recent M&A Activity and Strategic Collaborations
5.1.5.1 Acquisition of Katakura’s Research Institute of Biological Science
5.1.5.2 Collaboration with IDEXX Labs to Expand into Animal Diagnostics
5.2 Arkray
5.2.1 Global Presence
5.2.2 R&D
5.2.3 IVD Product Portfolio
5.2.4 Sales and Recent Performance Analysis
5.2.5 IVD Revenue Forecast 2016-2027
6. Emerging In Vitro Diagnostic Companies, 2017
6.1 Pipeline and Other Companies: An Overview, 2017
6.2 Other Prominent In Vitro Diagnostic Players
6.3 Dako (Agilent Technologies)
6.3.1 Sales and Recent Performance Analysis
6.3.2 M&A Activity and Other Key Developments
6.4 Genomic Health
6.4.1 Sales and Recent Performance Analysis
6.4.2 R&D Capabilities
6.4.2.1 TAILORx Clinical Trial
6.4.2.2 RxPonder Trial
6.4.2.3 Partnership with Oncomed
6.5 Laboratory Corporation of America (LabCorp)
6.5.1 Sales and Recent Performance Analysis
6.5.2 In Vitro Diagnostics
6.6 Recent M&A Activity and Other Key Developments
6.6.1 Agreement with Medco Health Sciences
6.6.2 Acquisition of Monogram Biosciences
6.6.3 Non-Exclusive License Agreement with Merck
6.6.4 Acquisition of Genzyme Genetics
6.6.5 Partnership with ARCA Biopharma
6.7 MDxHealth
6.7.1 Sales and Recent Performance Analysis, 2015
6.7.2 R&D Capabilities
6.7.3 In Vitro Diagnostics
6.7.3.1 PharmacoMDx
6.7.3.2 PredictMDx for Brain Cancer
6.7.3.3 PredictMDx for Colon Cancer
6.7.3.4 Partnership with GSK
6.8 Myriad Genetics
6.8.1 Sales and Recent Performance Analysis
6.8.2 R&D Capabilities
6.8.3 In Vitro Diagnostics
6.8.3.1 Myriad RBM
6.8.4 M&A Activity and Recent Partnerships
6.8.4.1 Agreement with BioMarin Pharmaceutical
6.8.4.2 Acquisition of Myriad RBM
6.8.4.3 Strategic Debt Investment in Crescendo Bioscience
6.8.4.4 Agreement with Cephalon
6.8.4.5 Agreement with PharmaMar
6.9 QIAGEN
6.9.1 Sales and Recent Performance Analysis
6.9.2 Continued Expansion in the Emerging Markets
6.9.3 R&D Capabilities
6.9.3.1 More than 15 Projects to Co-Develop and Market Diagnostic Products
6.9.3.2 Provider of Choice for Molecular Diagnostic Tools
6.9.4 Recent M&A Activity and Other Developments
6.9.4.1 Acquisition of Cellestis Ltd.
6.9.4.2 Acquisition of Ipsogen
6.9.4.3 Partnership with Pfizer
6.9.4.4 Partnership with Eli Lilly
6.9.4.5 Acquisition of SABiosciences Corporation
6.9.4.6 Acquisition of DxS Ltd (Now QIAGEN Manchester)
6.9.4.7 Acquisition of Explera s.r.l
7. Conclusions
7.1 In Vitro Diagnostics: Attractive Segment of the Healthcare Market
7.2 Big Pharma Dominated the IVD Market in 2015
7.3 The Rise of ‘Generic Medical Devices’
7.4 What Will Succeed in the IVD Market?
7.5 Small Companies Can Have a Big Impact on the Industry and Market to 2027
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
【レポート販売概要】
■ タイトル:医療機器リーダーシリーズ:体外診断用医療機器(IVD)の上位企業2017-2027■ 英文:Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2017-2027-Leading IVD Companies in the US, Europe and Asia
■ 発行日:2016年11月
■ 調査会社:visiongain
■ 商品コード:VGAIN61207
■ 調査対象地域:グローバル
- ガラス添加物の世界市場分析:製品別(金属酸化物、ナノ粒子、希土類金属)、エンドユーザー別(包装、ビルディング・包装、電子機器)、セグメント予測、2014-2025The global glass additives market is expected to reach USD 1.56 billion by 2025, according to a new report by Grand View Research, Inc. Increasing consumption of colored and specialty glass in the packaging industry has been a major factor driving the glass additives market growth. Rising demand from food & beverage industry in addition to the growing popularity for customized glass wares across i …
- 業務用サービスロボットの世界市場の世界市場Professional service robots have the tendency to work closely with humans and can be used in a wide application ranging from surveillance to underwater inspection. They provide convenience and safety, among other benefits, thus creating demand worldwide. Technavio expects the global professional service robotics market to multiply at a remarkable rate of nearly 16% during the forecast period. Toda …
- アメリカン・ウイスキーの世界市場2016-2020About American Whiskey The production and labeling of American whiskey has to be under the Title 27 of the US Code of Federal Regulations. American whiskey was traditionally produced within the boundaries of the US and can be classified as bourbon, Tennessee whiskey, rye whiskey, corn whiskey, wheat whiskey, blended whiskey, and malt whiskey. With the exception of Tennessee whiskey and Canadian wh …
- 通信キャリア向け運用・管理ソリューションの世界市場:料金請求管理、ネットワーク管理、プロビジョニング及びアクティベーション、NG SDP等About Telecom Operation Management System A telecom operation management system is the integration of several solutions to enhance the efficiency of telecom operators as well as streamline telecom operations and businesses. The telecom operation management system comprises several components such as telecom consumer billing management, network management, provisioning and activation, and NG SDP. I …
- 家庭用真空掃除機の世界市場2017-2021About Household Vacuum CleanerVacuum cleaners are electrical appliances that use an air pump to suck up dirt and dust from floors and other surfaces. The dust is secured in a dust bag that can be emptied later. Different types of vacuum cleaners are available depending on the type of surface to be cleaned. Vacuum cleaners clean surfaces with ease over a short time. Technavio’s analysts forecast th …
- ホワイトボックスサーバの世界市場予測(~2022年):ラックサーバ、タワーサーバ、ブレードサーバ、密度最適化サーバーThe white box server market is expected to reach USD 14.43 Billion by 2022, at a CAGR of 18.6% between 2016 and 2022. The growth of this market is propelled by the factors such as low cost and high degree of customization, growing number of data centers, increasing adoption of white box servers among end users, growing number of data centers, rising adoption of open platforms such as Open Compute …
- 世界のITサービス市場:ITコンサルティング/導入/ITアウトソーシング(ITO)/ソフトウェア/ハードウェアサポートサービスAbout IT Services IT services refer to the application of business and technical expertise that help organizations in creation, management, and optimization of information and business processes. IT services are provided to help customers accomplish their requirements and business goals. IT services are also required to manage IT systems. They are process-focused and are needed to improve customer …
- MUGの世界市場2015MUG (CAS 6160-80-1) Market Research Report 2015 aims at providing comprehensive data on market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes description, covers its application areas, manufacturing methods, patterns. It captures market trends, pays close attention to manufacturers and names suppliers. Besides, the report provides prices in regional m …
- エチレンオキシド及びエチレングリコールの世界市場2016-2020About Ethylene Oxide and Ethylene Glycol Ethylene oxide is a chemically reactive material. It is used for manufacturing ethylene glycols, glycol ethers, ethanolamines, surface-active agents, and polyether polyols. Ethylene glycol is a clear, viscous, versatile organic compound that is a hydroscopic liquid at room temperature. It is used in the manufacture of polyester films, fibers and PET resins, …
- 部分発作治療のグローバル臨床試験動向(2014年H2)Partial Seizure Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Partial Seizure Global Clinical Trials Review, H2, 2014" provides data on the Partial Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Partial Seizure. It includes an overview of the trial numbers and their recruitment status as …
- 航空宇宙防衛分野電化製品のグローバル市場トレンド及び予測2011-2018(Aerospace-Defense Electronics:Global Trends, Estimates and Forecasts, 2011-2018)Global Market Watch: The aerospace and defense market is expected to reach US$248.2 billion by 2018 primarily supported by the application sectors engineering / aeronautics (body), inflight entertainment, avionics and engine. Globally, avionics and engine together account for approximately 39% of the market are expected to support the aerospace and defense electronics industry going forward. Geogr …
- 2014年戦略提言:H. Pylori診断検査市場The report presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- AVP-825 (片頭痛/Migraine):医薬品市場予測及び分析(~2023)AVP-825 (Migraine) - Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products a …
- European HIV/AIDS Diagnostics Market 2014: Hospitals, Blood Banks, Public Health Labs, Commercial Labs–Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT ProceduresComplete report $3,950. DataPack (test volumes, sales forecasts, supplier shares) $2,500.Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following …
- セルラーM2M VASのグローバル市場(2014-2018)About Cellular M2M VAS M2M communication is used for automated data transmission between two machines. In M2M communication, a device is attached to a machine that captures an event relayed over a network delivering data to applications. In cellular M2M connections 2G, 3G, LTE, and CDMA communication technologies are used to establish connections and communication between two machines. The cellula …